Susquehanna International Group, LLP Poseida Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 15, 2024
SELL
$2.0 - $3.46 $49,600 - $85,808
-24,800 Reduced 43.97%
31,600 $92,000
Q1 2024

May 07, 2024
BUY
$2.76 - $4.13 $41,124 - $61,537
14,900 Added 35.9%
56,400 $179,000
Q4 2023

Feb 14, 2024
BUY
$1.83 - $3.51 $75,945 - $145,665
41,500 New
41,500 $139,000
Q3 2022

Nov 14, 2022
BUY
$2.43 - $4.51 $36,207 - $67,199
14,900 New
14,900 $53,000

Others Institutions Holding PSTX

# of Institutions
97
Shares Held
38.5M
Call Options Held
377K
Put Options Held
22.2K
View Full List

About Poseida Therapeutics, Inc.

PSTX Quotes by TradingView
  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $237M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email